This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Ard Tijsterman, MSc
Chief Executive Officer at Biosana Pharma BV


Biotechnologist and entrepreneur with more than 30 years of experience in drug development, bioprocessing and project management. Former Head of Manufacturing & PD at Chiron Corp. Co-founder and former MD of Xendo (CMC/RA consultancy & phase I unit with 250 staff, sold to PPG & QPS) and Tarpon Biosystems (continuous chromatography, sold to Pall Corporation). Currently CEO of BiosanaPharma, a Dutch/Australian company. Biosanapharma focusses on: 3C continuous manufacturing of mAbs, Super Critical CO2 spray drying for large protein formulation and delivery (e.g. mAbs) and product development (biosimilars & biohybrids).

Agenda Sessions

  • Continuous USP using HCD Perfusion and Alternating Bioreactors

  • Integrated Continuous Countercurrent Processing of mAbs – Batch Processing Made Continuous